Background: Despite considerable medical advances, arthroscopy remains the only definitive means of superior labrum anteriorposterior (SLAP) lesion diagnosis. Natural shoulder anatomic variants limit the reliability of radiographic findings and clinical evaluations are not consistent. Accurate clinical diagnostic techniques would be advantageous because of the invasiveness, patient risk, and financial cost associated with arthroscopy.
diagnosis, natural anatomic variants limit the reliability of all radiographic diagnoses. Furthermore, parallel to arthroscopy, radiography can be invasive, expensive, and dangerous, causing life-threatening allergic reactions 5 in some patients, rendering radiography an imperfect means of SLAP lesion detection. 3, 4, 7 More than 20 provocative tests for the clinical evaluation of SLAP lesions are proposed in the literature. In most cases, the evaluation of the physical examinations by the original authors reveals promising accuracy for the detection of SLAP lesions. 2, 16, 17, 21, 22, 32 However, secondary studies often fail to reproduce the initial findings, typically reporting much lower values for the sensitivity and specificity of the physical examination tests. 8, 11, 14, 19, 23, 24, 31 The discrepancies between the findings most likely reflect 2 primary difficulties: (1) the clinical detection of SLAP lesions is hindered by the fact that SLAP lesions are rarely isolated, meaning they are frequently accompanied by other various glenohumeral lesions that are potential sources for labral symptoms 3 ; and (2) differences in study protocols and problems associated with the methods used to verify accuracy of the physical examinations make comparisons between studies difficult. 8 The bulk of the literature assesses SLAP lesion tests by determining diagnostic accuracy through a single verification method. Typically a patient with a suspected SLAP lesion performs the provocative tests of interest in a clinical setting before shoulder arthroscopy. The outcome of the SLAP lesion test is then verified with conclusive arthroscopic findings. [7] [8] [9] 11, 14, 19, 20, 24 The results of these comparative studies have significant quantitative discrepancies, but a fundamental qualitative conclusion recurs-no single SLAP lesion test has the sensitivity or specificity to independently determine the presence or absence of a SLAP lesion. [7] [8] [9] 23 Although previous studies assess the diagnostic accuracy of specific SLAP lesion tests, they do little to explain the reasons behind their apparent failure and rarely suggest or point to any means of improving the performance of the tests.
Clinically based evaluations of SLAP lesion tests account for the majority of studies to date; however, studies have also assessed test accuracy by attempting to validate the fundamental design behind various SLAP lesion tests. 10, 25, 27, 30 Provocative SLAP lesion tests, by definition, function to provoke labral symptoms (primarily pain) as a positive diagnostic sign, by reenacting 1 of 2 injury mechanisms. The first mechanism elicits active tension in the long head biceps brachii (LHBB) tendon and is typically associated with an acute traction trauma to the arm or from the accumulation of microtrauma events over time from repetitive movements such as overhead throwing. The tensile load produced in the biceps tendon can pull and damage the superior labrum, the functional link between the insertion of the biceps tendon and the glenoid rim. The second injury mechanism produces passive compression of the humeral head and is often associated with a fall to outstretched arms. The compressive load causes superior humeral head translation within the glenohumeral joint and can result in a collision between the humerus and labrum, potentially damaging the soft tissue of the labrum. 1 The ability of proposed SLAP lesion tests to reproduce the injury mechanisms that they were designed to replicate has been examined from several perspectives including anatomic, 10, 25, 27 kinematic, 18 and electromyographic 10, 30 methods and results illuminate the importance of design validation during the development of clinical testing procedures.
The purpose of this study was to assess the ability of 8 provocative tests to create active tension in the biceps tendon by characterizing the behaviors of glenohumeral jointstabilizing muscles, with particular interest in the LHBB muscle activation and LHBB muscle selectivity. Tests that elicit larger activation of the LHBB should serve as better diagnostic indicators for SLAP lesions. Other jointstabilizing muscles were also examined to determine individual muscle contributions during the tests, outlining the ability of each test to selectively activate the LHBB. Selectively activating the LHBB should reduce diagnostic complications related to the frequent presence of other confounding injuries with SLAP lesions.
MATERIALS AND METHODS

Participants and Institutional Review Board Approval
A cohort of 21 healthy volunteers composed of 11 female (24.7 6 6.7 years, 168.4 6 5.3 cm, 66.9 6 9.1 kg) and 10 male (29.4 6 10.6 years, 178.1 6 6.6 cm, 80.0 6 6.4 kg) patients with right arm dominance and without any preexisting shoulder conditions were recruited as participants in this study. Screening of the volunteers was based on verbal confirmation of no shoulder injury; a diagnostic evaluation was not conducted. All procedures were approved by the institutional review board and all participants read and signed a statement of informed consent before the start of testing.
Electromyography Apparatus and Participant Preparation and Electrode Placement
Electromyography (EMG) was used to record muscle activity for 7 muscles surrounding the dominant glenohumeral joint including the long and short heads of the biceps brachii (LHBB and SHBB), anterior deltoid (DELT), pectoralis major (PECT), latissimus dorsi (LAT), infraspinatus (INFRA), and supraspinatus (SUPRA). Each participant was instrumented with one 44-gauge fine-wire indwelling electrode and 2 surface bipolar silver-silver chloride EMG electrodes (Noraxon USA Inc, Scottsdale, Arizona). The surface electrodes were positioned over the muscle belly and parallel with the orientation of the muscle fibers as suggested by Cram and Kasman. 6 An additional surface electrode was placed on the acromion process of the nondominant shoulder to serve as a reference. Because of the location of the SUPRA deep to the trapezius, the indwelling electrode was necessary to acquire SUPRA activity. Using sterile techniques, an emergency medical technician who was trained specifically for this task by a medical doctor placed the fine-wire indwelling electrode. The EMG data were recorded using the Vicon Nexus Software (Vicon, Los Angeles, California) at 1250 Hz using a Noraxon Telemyo 900 EMG system (Noraxon USA).
EMG Analysis
The EMG signals were analyzed using custom MATLAB software (The MathWorks, Inc, Natick, Massachusetts). A traditional filtering method was used for the EMG signals for the LHBB, SHBB, DELT, PECT, and SUPRA. Each signal was smoothed by implementing a root mean square algorithm in combination with a 20-millisecond forward moving window average. The signals were normalized to a percentage of effort based on their respective maximum voluntary isometric contraction (MVIC) peak EMG signal amplitudes, ideally resulting in a muscle activation range of 0% to 100%. Maximum normalized muscle activation selectivity was determined for each muscle during each test. The raw data for the DELT and LAT were processed by the same method, but the MVIC peak signals were further examined to ensure that the peak amplitude of the signal did not overlap with a peak from the heartbeat artifacts.
Muscle activation and muscle selectivity were calculated to characterize muscle behavior during the provocative tests, with particular interest in the LHBB behavior. Muscle activation was used to determine how effective each SLAP lesion test was at causing individual muscles to activate and was defined as the mean of the peak normalized muscle signals elicited during the 3 trials. The ability of each provocative test to isolate the LHBB is important for diagnosing SLAP lesions because of its common association with other shoulder lesions. Therefore, in this study, a ratio indicating the ability of each test to selectively activate each muscle was calculated. The muscle selectivity for each test was defined by the ratio of the peak normalized activation of the muscle of interest over the sum of peak normalized activations for all 7 muscles examined, such that a selectivity ratio of 1.0 for any muscle, N, would indicate that muscle N was the only active muscle contributing to the EMG signal while the other 6 muscles remained inactive. For each test, the general selectivity calculation for muscle N was defined as follows:
where N_Selectivity Ratio is the selectivity ratio of muscle N, N is the muscle of interest (LHBB, SHBB, DELT, PECT, LAT, INFRA, or SUPRA), and A N is the peak normalized muscle activation of muscle N.
Participant Protocol: MVICs and Provocative Tests
Using established EMG protocols, each subject was asked to perform MVICs for each muscle of interest on a Biodex System II dynamometer (Biodex Medical Systems, Shirley, New York). Modifications were made to the MVIC recommendations of Cram and Kasman, 6 Hintermeister et al, 12 and Rowlands et al 26 to accommodate for the use of the Biodex system (Table 1) . For each trial, 6 seconds of data were recorded to ensure that the entire burst of muscle activity was captured during each MVIC. The participants performed 3 trials for each MVIC and were asked to maximally contract for a count of 3 seconds. Participants rested for 30 seconds between MVIC trials to avoid fatigue effects. For each MVIC, the peak amplitude of the EMG signal among the 3 trials was used to normalize the provocative test data.
Similarly, 7 provocative tests were performed based on the descriptions of the original authors but with modifications to accommodate for use of the Biodex System. These tests were chosen based on the findings of a preliminary pilot study that evaluated clinical tests from relevant literature that were designed to reenact either SLAP lesion injury mechanism. 18 Again, the participant performed 3 trials for a 3-second count for each test, 6 seconds of data were recorded for each trial, and the participants rested for 30 seconds between trials.
Provocative Test Descriptions and Study Modifications
The modifications for each MVIC and 6 of the 7 SLAP lesion tests utilized the Biodex System for the purpose of reducing the influence of variances in muscle behavior and test performance. Tests requiring static resistance against an applied load maintained the static participant position through the stationary pre-setup of the Biodex System. Tests requiring dynamic resistance to an applied load were controlled by the Biodex System, allowing a constant velocity regardless of the force applied by the participant. Images of each test setup are shown in Figure 1 .
Active Compression Test (ACPD and ACPU)
The active compression test has 2 positions, palm down (ACPD) and palm up (ACPU), which vary only by rotation of the arm. The patient is standing with the elbow in full extension, the shoulder is flexed to 90°and adducted 10°t o 15°medial to the sagittal plane. For ACPD, the forearm is fully pronated and the glenohumeral joint is maximally internally rotated such that the thumb points down. The patient is asked to resist a uniform downward load applied to the arm by the clinician. For ACPU, the initial patient positioning is unchanged except the arm is externally rotated such that the palm faces up. Again, the patient is asked to resist a uniform downward load applied by the clinician. 22 For the purpose of analysis and because of the nature of the participant population as a control group having no history of shoulder injury and therefore being asymptomatic, this study treated ACPU and ACPD as 2 independent tests. Both tests were modified such that the participant was seated in the Biodex. The orientation of the participant's arm remained true to O'Brien's original description of the test, but the participant was asked to resist the stationary position of the Biodex arm by attempting to lift the arm superiorly for both ACPD and ACPU.
Speed's Test
According to the original description, the patient is standing and resists a downward force applied to the upper extremity with the elbow extended, forearm supinated, and arm elevated to 90°. 2 In this study, the orientation of the arm remained similar to the original definition, but Speed's test was performed dynamically, mimicking a variation of the original test that is commonly referred to as the ''dynamic Speed's test''. 31 The participant's arm started hanging beside and parallel to the body, and then the participant was asked to raise the arm (flex the shoulder) with as much force as possible to 90°. Regardless of the force applied by the participant, motion was restricted to a constant velocity by the Biodex System of 60 deg/sec.
Pronated Load Test (ProLoad)
In the original description, the patient is in the seated position with elbow flexed to 90°, the arm is abducted to 90°, maximally externally rotated, and the forearm is fully pronated. The participant is then asked to perform an isometric contraction of the biceps. 31 The pronated load test was negligibly modified for this study. The participant sat in the original orientation in the Biodex System, which was set up such that the arm was supported just proximal to the elbow. The participant was asked to perform an isometric bicep contraction (pronated curl), which was resisted by the static setup of the Biodex System.
Biceps Load I Test (Bicep I)
The patient is in the supine position when an anterior apprehension test is performed starting with the arm abducted 90°, elbow flexed 90°, and the forearm fully supinated according to its original definition. 17 Bicep I was modified such that the participant was seated in the same position as ProLoad, except the forearm was fully supinated. The participant was asked to perform a bicep contraction (curl), which was resisted by the static setup of the Biodex System.
Biceps Load II Test (Bicep II)
The patient is supine with the arm abducted to 120°, the elbow flexed to 90°, and the forearm fully supinated. The patient is then asked to flex the elbow against the resistance of the clinician. 16 For this study, the modification for bicep II paralleled those made to bicep I except the arm was abducted to 120°instead of 90°.
Resisted Supination External Rotation Test
The authors describe putting the patient in the supine position with the scapula near the edge of the table; the patient's arm is supported by the physician at the wrist, with the arm is abducted to 90°and the elbow is flexed between 65°and 70°. The clinician then externally rotates the arm while the patient is asked to supinate the forearm. 21 The resisted supination external rotation (RSER) test was unchanged for this study. A licensed athletic trainer performed RSER with each participant in the supine position using the Biodex only as an examination table.
Supination Sign Test (Yergason's)
In the seated position with the elbow flexed to 90°and forearm fully pronated, the patient is asked to attempt supination of the forearm while the physician resists the motion while holding the wrist. 32 Yergason's was scarcely modified; the participant maintained the defined orientation but with the forearm fastened to the static Biodex arm. The patient was asked to attempt to supinate the forearm against the static setup of the Biodex while maintaining the specified elbow and shoulder position.
Statistical Analysis
Statistical analysis was conducted using SPSS statistical software (SPSS Inc, an IBM company, Chicago, Illinois) to determine significant differences in maximum muscle activations and muscle selectivities for each test, between tests, and between male and female groups. An a priori power analysis was conducted based on previous research and a minimum sample size of 20 participants was determined. A repeated-measures analysis of variance (ANOVA) was performed to identify significant differences between provocative tests for each individual muscle. A pairwise t test post hoc analysis was performed to compare results between each test using a P value sliding scale Bonferroni adjustment. 13 Likewise, a paired-sample t test was used to examine potential differences in muscle activation (P = .05) between male and female groups.
RESULTS
A post hoc pairwise comparison between male and female patients showed no differences between male and female groups for any muscle or for any provocative test with all P values exceeding .05. Therefore, male and female data were pooled for all subsequent statistical analyses. For each individual muscle, the repeated-measures ANOVA found significant differences in both muscle activation and muscle selectivity among the 8 provocative tests (P \ .05).
To determine which provocative tests resulted in the greatest activations for the individual muscles, 28 pairwise comparisons between the 8 tests were made for each muscle. Each muscle analyzed showed a significant difference in peak muscle activity between 1 or more of the pairs of provocative tests with the exception of the LAT. Specifically, the LHBB demonstrated a significant difference (P \ .0001) in activity between tests. The 8 statistically significant pairwise comparisons enabled the tests to be characterized into 1 of 2 performance groups based on their respective LHBB activation: high performing and low performing. Speed's, ACPU, bicep I, and bicep II tests were ''high performing,'' eliciting the largest mean peak normalized EMG amplitudes without statistical differences among the 4 tests, while RSER, Yergason's, ACPD, and ProLoad were classified as ''low performing'' ( Figure 2 ). The mean normalized peak activations (% MVIC) for each muscle elicited during all 8 tests are noted in Table 2 .
The statistical analysis with regard to muscle selectivity for each test proved similar to those for muscle activation. There were significant differences in muscle selectivity across the provocative tests (P \ .0001). A post hoc pairwise comparison showed that 1 or more pairs of tests had significant differences in muscle selectivity for each muscle with the exception of the LAT and INFRA. The 11 statistically significant pairs allowed the tests to be categorized into high-and low-performance groups based on LHBB selectivity. The RSER, bicep I, bicep II, and Yergason's tests were high performing, recruiting the LHBB more selectively than the ProLoad, Speed's, ACPU, and ACPD tests, which were categorized as low performing ( Figure  3 ). Again, there was no statistical difference among tests within each group. The mean selectivities of each muscle for all 8 tests are noted in Table 3 .
DISCUSSION
The aim of this study was to characterize the muscle behavior of 7 glenohumeral joint-stabilizing muscles, focusing on the LHBB, during 8 modified provocative tests that were designed to detect SLAP lesions by loading the biceps tendon in tension through LHBB activation. The active tension in the biceps tendon is thought to reproduce the injury mechanism of a SLAP lesion, which should provoke a response from suspected SLAP lesion patients yielding a positive diagnostic sign. 1, 31 In this study, bicep I and bicep II were the most promising SLAP lesion tests according to their favorable LHBB behavior, eliciting high LHBB activity while remaining highly selective for the LHBB, indicating these 2 tests should function effectively as assessment tools for the clinical evaluation of SLAP lesions.
The magnitude of LHBB activation during each of the clinical evaluations is a measure of the sensitivity of the maneuver to incite active tension in the LHBB tendon, which should increase the likelihood of detecting a SLAP tear. Although EMG signal amplitude cannot be directly related to muscle force in most cases, the tests that most strongly activate the LHBB should provide relatively higher traction forces to the superior labrum. Speed's, ACPU, bicep I, and bicep II tests produced the largest LHBB activities, reaching above 90% MVIC, suggesting that a greater respective load was applied to the biceps tendon during these tests. Although none of the tests apply loads sufficient to produce a SLAP lesion, Speed's, ACPU, bicep I, and bicep II tests created the largest LHBB activation and therefore reproduced the presumed injury mechanism more effectively than the other 4 low-performing tests (RSER, Yergason's, ACPD, and ProLoad). Although SLAP lesion test assessment is prevalent in the literature, comparison between studies is difficult due to the lack of overlap of tests between similar studies. However, 2 studies support the findings of this study in that ACPU and bicep II have both been reported to elicit large LHBB EMG amplitudes. 10, 30 The LHBB selectivity served as an equally important variable to consider for characterizing LHBB behavior and for assessing SLAP lesion tests, as it is an indicator of test specificity. The diagnostic accuracy of SLAP lesion tests is often hindered by the frequent occurrence of other glenohumeral lesions, such as rotator cuff tears, which make determining the origin of shoulder symptoms challenging at best. 9, 15, 19, 29 Consequently, provocative tests that are able to isolate the LHBB would be beneficial because high LHBB selectivity denotes a lesser contribution from other joint-stabilizing muscles that can produce a false-positive SLAP lesion diagnosis. The RSER, bicep I, bicep II, and Yergason's tests were ''high performing'' with regard to selectively recruiting the LHBB. Each high-performing test resulted in LHBB selectivity between 0.23 and 0.25, compared with the range of 0.12 and 0.16 selectivity for the low-performing tests (ProLoad, Speed's, ACPU, and ACPD). Unfortunately, LHBB selectivity is not reported elsewhere in the relevant literature, but these results concur with the findings of the pilot study. 18 The 2 overall top performing SLAP lesion tests, bicep I and bicep II, elicited large LHBB activation while demonstrating high LHBB selectivity. The clinical implications derived from the remaining tests that were high performing in only a single area of LHBB behavior, either highly specific (activation-ACPU and Speed's) or highly sensitive (selective-RSER and Yergason's), may be limited if used on their own. Top-performing SLAP lesion tests, which elicited large LHBB activation and were highly selective for the LHBB, should be closely examined in hopes of defining the characteristics that may be responsible for their promising LHBB behavior.
Bicep I and bicep II are very similar tests, varying only by the amount of abduction of the shoulder joint. Bicep I, bicep II, Speed's, and ACPU all have desirable behavior in 1 or both measures of muscle activation. On the basis of our results, future studies should examine whether these tests would be more efficacious when used in combination. All 4 tests share similar design characteristics relating to location of the applied load, forearm orientation, joint position, and line of pull during either a static or dynamic provocative test designed to activate the LHBB. Each of these tests was performed with a supinated forearm and required active resistance to an external load applied perpendicular to the palm of the participant's hand. Each high-performing test was performed in 1 of 2 joint positions that placed the LHBB and biceps tendon in a direct line of pull with the superior labrum. The first joint position (Speed's and ACPU) flexed the shoulder to a maximum of 90°with the elbow fully extended. The second joint position (bicep I and bicep II) had the shoulder abducted at or above 90°w ith the elbow flexed at 90°. The major difference among these 4 tests is the way the tests are performed; Speed's, as performed by many clinicians, is a dynamic test, while bicep I, bicep II, and ACPU are static tests, in which the patient resists the load without the ability to move.
In this study, ACPU and Speed's were high performers with regard to LHBB activation, but from a biomechanical standpoint and from an examination of the actual physical movements involved in the 2 tests, there are clear differences. These tests vary substantially in that ACPU is intended to be a static test, while Speed's is normally performed dynamically. Furthermore, these tests have slight but noteworthy differences in patient orientation and type of movement. The ACPU places the patient's arm in 30°of horizontal adduction while Speed's test is confined to the sagittal plane. These small but clear and potentially important differences may prove to be an avenue for understanding the role and importance of SLAP lesion test characteristics and design. A close examination of these kinds of test characteristics and their relation to test performance may help identify a means of improving the clinical detection of SLAP lesions by enabling a new direction to be taken in the design of the clinical tests.
The active compression test utilizes 2 different arm positions. The participant is first tested with the arm flexed 90°, horizontally adducted 30°, and internally rotated so that the thumb points downward (ACPD). Then the arm is fully supinated and the test is repeated (ACPU). If pain is elicited in the first maneuver and alleviated in the second maneuver, the test is said to be positive for a SLAP lesion. 22 Assuming LHBB activation and the resulting tension in the biceps tendon are good predictors of a SLAP lesion, our findings on the ACPU test run contrary to O'Brien's original design. The ACPU test had greater peak LHBB activation than the ACPD test, meaning the ACPU test should create a greater tensile load along the biceps tendon and thus greater pain in the case of an actual SLAP lesion.
O'Brien's basis for the active compression test was founded upon cadaveric tests that approximated acromioclavicular joint compression at several joint positions. 22 O'Brien selected the 2 positions that resulted in the greatest and least loads at the acromioclavicular joint, ACPD and ACPU, respectively. O'Brien's methods accounted for the ''active compression'' that could be placed on the injured labral area by direct contact with the greater tuberosity but did not account for any tensile loads caused by activation of the LHBB during the clinical test. This may be why many of the clinical-based studies of the active compression test have resulted in relatively low specificity and sensitivity. 11, 19, 21, 29 This result demonstrates that there are multiple diagnostic mechanisms to take into account when designing either a single clinical test or when attempting to combine multiple clinical tests.
Although the focus of this study was the behavior of the LHBB, 6 other joint-stabilizing muscles were studied to allow for LHBB selectivity calculations and to facilitate characterizing any other muscle behaviors or patterns. Peak muscle activities and muscle selectivity were examined for all remaining muscles (SHBB, DELT, PECT, LAT, INFRA, and SUPRA), and statistical analysis revealed that it may be unnecessary to monitor the LAT and INFRA during these tests, because none of the tests had a significant difference in terms of activation of the LAT or in selectively isolating either the LAT or INFRA muscles.
The primary limitation of this study is that the participants had no history of shoulder injury; therefore, labral symptoms were not used as a means to assess SLAP test performance. Also, the healthy participant pool may misrepresent SLAP lesion patients because of the potential for differences in muscle behavior between healthy participants and patients with labral injury. Furthermore, the EMG signals were all normalized based on peak activities elicited during MVIC, and results exceeded 100% in some cases and may make comparison between participants difficult. Specifically, the dynamic Speed's test, which had the largest mean activation (140.9% MVIC) among the tests, was not a surprising finding, as the dynamic movement was normalized to a static MVIC. Comparing activation during a dynamic test to data collected in a static configuration may not be optimal. For the static tests, LHBB activations were generally below or much less than that of Speed's, suggesting that the normalization procedure was more appropriate for those tests. However, in some tests, participants were able to achieve more than 100% MVIC in some muscles, which means either that the tests were more effective in isolating those muscles than the MVIC configurations, or that slight differences in positioning or in participant effort in the clinical tests and the MVIC tests affected the muscle activation values recorded. Recent studies utilizing arthroscopic verification for clinical tests have documented a drastic increase in SLAP lesion detection by using the indications of 2 or more SLAP tests, specifically when at least 1 test is highly sensitive and another is highly specific. 8, 23 Consequently, assessing the array of high-performing test combinations, utilizing various combinations of single-measure high-performance tests with various test characteristics, may have surprising results and prove worthwhile.
Although this study focuses completely on the amount of LHBB activation present during each of the clinical tests, there is a second diagnostic mechanism that needs to be addressed. There are many clinical tests available to clinicians that rely on compression of the injury site through translation of the humeral head within the glenoid socket instead of relying on muscle activation. Several examples of these clinical tests are the compression rotation, clunk, crank, and anterior slide tests. 31 While the effectiveness of these tests needs to be quantified, we are limited by the lack of current technology to accurately quantify motion of the humerus relative to the glenoid in vivo. Dynamic 3-dimensional imaging would be required to accurately quantify the translation of the humeral head and the resulting impingement upon the injury site.
Lastly, although difficult to determine and requiring a large pool of control and experimental data, comparisons between the muscle behaviors of a healthy population and those who have a suspected SLAP lesion may illuminate some general pattern differences that could be indicative of SLAP lesions and be useful for furthering clinical diagnostic techniques and accuracy.
CONCLUSION
In summary, modified versions of bicep I and bicep II resulted in the greatest LHBB activation and LHBB selectivity of the SLAP lesion tests in this study. The ACPU and Speed's tests resulted in the largest LHBB activation, but were not selective for the LHBB. Bicep I, bicep II, ACPU, and Speed's each elicit some promising LHBB behavior, and may be useful in combination to aid the clinical detection of SLAP lesions. These 4 tests utilize a unique range of test variables that may prove valuable for optimal SLAP test design and function. Future studies should evaluate the importance of these variables, incorporate joint torque analyses, and expand the scope of the study to include patients who have a suspected SLAP lesion to optimize, validate, and improve the diagnostic accuracy of provocative SLAP lesion tests.
